Patent ID: 8609693

Claim:
A method of treating thrombocytopenia in a human in need thereof which comprises administering a load dose of the compound 3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid or a pharmaceutically acceptable salt thereof, wherein the load dose of the compound, or pharmaceutically acceptable salt thereof, is an amount ranging from about 50 mg to about 150 mg administered from 2 to 4 times in a day for 1 to 14 days, or is an amount ranging from about 200 mg to about 600 mg administered once a day for 1 to 14 days, followed by the administration of a maintenance dose of the compound, or pharmaceutically acceptable salt thereof, wherein the maintenance dose of the compound, or pharmaceutically acceptable salt thereof, is an amount of from about 25 mg to about 150 mg a day for at least two additional days.